Buyer to Builder — The Invisible Layer of Patient Monitoring
A small sensor sits on a tripod across the room — no wearable, no camera, nothing taped to a chest — and it’s reading a heartbeat through the air. What does it take for a tool like that to survive contact with a real hospital?
In this episode of Signal & Symptoms, Dr. Junaid Kalia hosts — with co-hosts Dr. Harvey Castro and Ed Marx — a conversation with Nayan Patel, SVP of Transformation & Digital Health at Neteera and a career hospital CIO who spent decades buying health technology before he crossed over to building it. Neteera’s premise is radical subtraction: a deck-of-cards-sized, FDA-cleared radar sensor that continuously tracks heart rate, respiratory rate and movement with nothing worn and nothing to charge. The panel works through how the radar actually reads the body (ECG mapped to a ballistocardiograph), why “clinical grade” is not an Apple Watch, the ED-waiting-room-chair use case that started with a hard question, the retrospective study that flagged deterioration roughly five days out, and the one demand every CIO makes: don’t make me another dashboard
What you'll discover
- What Neteera actually is — the radar “tricorder,” ECG → BCG, through clothing and bedding
- How accurate is it? — ~95% and thousands of data points a night
- The ED waiting-room chair — the use case that started with a death in the waiting room
- Why vitals and trends matter (Junaid on the sepsis window)
- AFib and arrhythmia — the case for catching it early (a capability in progress)
- “Don’t make me another dashboard” — a CIO’s demand on any new system
- Home health, the elderly, and the “monitor my mother-in-law” problem
- Can a phone camera read your vitals? — a clinician’s blunt answer
- The five-day signal — what a 612-resident study actually measured
- Screening → verification: where this sits on the monitoring spectrum
- Who owns the medical record? (the panel’s open debate)
- Close — it always comes back to the patient
Referenced in the episode
- Neteera — contactless vital-signs monitoring (FDA-cleared)
- “The Glass is Full” (TGIF) — Nayan Patel’s LinkedIn newsletter
- Retrospective study — contactless monitoring flagging deterioration ~5 days early across skilled-nursing facilities
Connect with the guest
- Nayan D. PatelLinkedIn
Medical disclaimer. This conversation is for general informational purposes and is not medical advice. Listening does not create a doctor–patient relationship. Always consult a qualified clinician.